Upgrade to SI Premium - Free Trial

Citi cuts Acadia Pharmaceuticals price target to $33

September 24, 2026 12:18 PM
Citi analyst Yigel Nochomovitz lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $33.00 from $40.00, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles